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Abstract: Sequencing the human genome was a huge milestone in genetic research that 
revealed almost the total DNA sequence required to create a human being. However, in 
order to function, the DNA genome needs to be expressed as an RNA transcriptome. This 
article reviews how knowledge of genome sequence information has led to fundamental 
discoveries in how the transcriptome is processed, with a focus on new system-wide 
insights into how pre-mRNAs that are encoded by split genes in the genome are rearranged 
by splicing into functional mRNAs. These advances have been made possible by the 
development of new post-genome technologies to probe splicing patterns. Transcriptome-wide 
approaches have characterised a “splicing code” that is embedded within and has a 
significant role in deciphering the genome, and is deciphered by RNA binding proteins. 
These analyses have also found that most human genes encode multiple mRNA isoforms, 
and in some cases proteins, leading in turn to a re-assessment of what exactly a gene is. 
Analysis of the transcriptome has given insights into how the genome is packaged and 
transcribed, and is helping to explain important aspects of genome evolution. 
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1. Introduction 
The completion of the human genome sequence [1,2] brought together key scientific and philosophical 
questions, including exactly what we are as a species and individuals. However, in order to function, 
the genome has to be expressed. The primary expression product of the genome is RNA, and the 
complete set of all RNA molecules made through copying the genome into RNA is called the 
transcriptome (Figure 1). After transcription in the nucleus, mRNAs are translated into protein in the 
cytoplasm to yield the proteome while other RNAs have noncoding functions [3]. 
OPEN ACCESS 
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Figure 1. Information flow from the genome to the proteome. The genome represents an 
archive of information embedded in DNA. This information is transcribed as RNA to give 
the transcriptome, and then translated into protein to give the proteome. 
 
A key feature of human (and other eukaryotic) genes is their split exon-intron structure [4,5]. Figure 2 
shows the exon-intron structure of a typical human gene displayed on a genome browser [6]. The 
exons include the protein coding information of the gene while introns are the intervening sequences 
between them. The term exon refers to the fact that exon sequences are expressed in the mRNA made 
from the gene, as opposed to introns which are removed (intron refers to intragenic regions) [7]. The 
presence of introns within genes and the long intergenic sequences between genes mean that only a 
small fraction of the human genome is truly protein-encoding. To put some figures on this, human 
protein-encoding genes contribute ~33.5% of the human genome sequence [1,2] but exons alone 
comprise 2.94% of the genome [8]. Protein coding exons make up a smaller proportion still (1.2%) of 
the genome. This is because there are at least partially untranslated exons in every mRNA (some of 
which can have important regulatory roles), and some exons remain entirely untranslated (see below). 
Genes need to be transcribed over their full length (including both introns and exons) to generate 
precursor mRNAs (pre-mRNAs). Transcription of long genes represents a considerable energy 
investment by the cell. One of the longest genes in the human genome, DYSTROPHIN takes in the 
order of 16 hours to transcribe, yet produces a final mRNA of just ~14 kb that would have just taken 
~7 minutes to transcribe by itself, assuming an elongation rate of 2 kb/minute [9]. It is calculated that 
~95% of RNA does not leave the nucleus [10]. Nuclear-retained RNA includes intron sequences and 
some long ncRNAs that are also spliced but retained in the nucleus. 
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Figure 2. The intron-exon structure of a typical human gene displayed on the UCSC 
genome browser [6]. Introns are shown as lines (the “arrowheads” in the lines indicate the 
direction of transcription). Exons are shown as vertical bars. Coding exons are shown as 
thicker vertical bars than non-coding exon sequence. This example shows the NASP gene. 
The gene structures shown are “Refseq genes” that represent known human protein-coding 
and non-protein-coding genes taken from the NCBI RNA reference sequences collection. 
Notice that this single gene locus contains three distinct Refseq annotations containing 
different exon structures. Conserved sequences detected by comparative genomic 
information from 100 vertebrate genome sequences are shown at the bottom as a Phastcons 
plot—the higher values are most conserved, and often correspond to exons. 
 
The splicing reaction is catalysed by the spliceosome. While introns are generally discarded after 
splicing, some introns can yield functional RNAs after splicing (e.g., miRNAs) [11,12]. Spliceosomes 
themselves are multi-component machines containing five snRNAs and at least 200 proteins, making 
them one of the most complicated assemblies in the cell [13,14]. Spliceosomes assemble de novo 
around each intron to be removed. A typical gene containing eight exons would require the assembly 
of eight spliceosomes to create a functional mRNA. Input of energy is required for spliceosomes to 
properly assemble through multiple ATP-dependent RNA helicases and other energy consuming 
proteins (including GTPases) [15]. 
Prior to completion of the human genome sequence, research into splicing typically looked at single 
genes and exons as models. However, while these detailed studies continue to be very important, the 
advances in genomics catalysed by genome sequencing projects have spawned parallel advances in 
transcriptomics, enabling a much broader system-wide dissection of RNA processing pathways. Here I 
review some of these new insights. While the focus here is on pre-mRNA splicing, transcriptome-wide 
analyses have also been directed at other aspects of genome expression, including RNA editing, RNA 
stability, expression of ncRNAs, polyadenylation and translation. 
2. The Human Genome Sequence Has Led to New Global Insights into the Control of Splicing 
In the 1980s examination of a limited number of genes led to the identification of short conserved 
sequences called 5' and 3' splice sites at exon-intron junctions [16]. The availability of the human and 
other genome sequences have enabled these studies to be extended genome-wide [17]. Most human 
exons are spliced together by a single kind of major spliceosome that recognises most 5' and 3' splice 
sites. In addition a second minor spliceosome exists in parallel that decodes a smaller subset of intron–exon 
junctions [18]. This minor spliceosome has a different but overlapping complement of snRNAs to the 
major spliceosome. Recent transcriptome-wide data show a key snRNA component in the minor 
spliceosome (called U6ATAC) is an important gene expression switch controlling patterns of splicing [19]. In 
the rest of this review the activities of the major and minor spliceosomes are not separately distinguished. 
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The conserved 5' and 3' splice site sequences encoded in the genome at exon-intron junctions are 
quite short. Furthermore, scattered within introns are short sequence elements called pseudoexons. 
Pseudoexons “look like” exons in that they have 5' and 3' splice sites, but are not selected as exons by 
the spliceosome. Estimates from model human genes suggest pre-mRNA splicing is remarkably 
accurate [20]. However, transcriptome-wide analyses of splicing patterns using RNAseq do detect 
some errors in splicing (at a rate of around 0.7% errors/intron)—these errors have been termed “noisy 
splicing”, and might contribute to gene and protein evolution by enabling new mRNA isoforms to be 
made even at low frequencies [21]. 
The spliceosome uses several mechanisms to accurately decode exon/intron structure using 
information embedded in the transcriptome. Firstly, in humans and most vertebrates, spliceosomes 
recognise exons from introns through a process called exon definition [22–24]. The advantage of exon 
definition is that since exons are quite small they should be easier to identify as discrete units 
compared most (considerably longer) vertebrate introns. In exon definition, early spliceosome 
components bind to the pre-mRNA and “flag” exons to be spliced together. Following exon definition, 
pairs of exons are then joined together by splicing which removes the intervening intron sequences. 
Amongst the early binding components of the spliceosome involved in exon definition are the U1 
snRNP RNA-protein complex that recognises the 5' splice site, and a protein dimer which recognises 3' 
splice sites called U2AF (U2AF65 and U2AF35 are the two proteins in the dimer). 
A second mechanism that facilitates accurate decoding of the genome is the presence of a splicing 
code that helps to differentiate between exons and introns in pre-mRNA. Before the sequencing of the 
human and other eukaryotic genomes, the important sequences controlling splicing of an exon were 
usually worked out on a gene by gene basis, using a finite number of model exons. The importance of 
exon sequences outside the splice junctions for splicing were first identified in pioneering experiments 
using model exons in the FIBRONECTIN and β globin genes [25,26]. It is now known that pre-mRNAs 
each contain multiple short nucleotide sequences that can enhance or silence splicing of their 
associated exons [27–29]. Exon sequences can function as exonic splicing enhancers (abbreviated 
ESEs) that help the spliceosome to recognise exons, or exonic splicing silencers (abbreviated ESSs) 
that inhibit spliceosome recognition by the spliceosome. Similarly, intron associated sequences can 
function as intronic splicing enhancers (abbreviated ISE) or Intronic Splicing Silencers (abbreviated 
ISSs). Splicing enhancers are bound by proteins or complexes of proteins, including the SR proteins 
that contain domains enriched in serine and arginine residues, and splicing silencers are frequently 
bound by heterogeneous ribonucleoproteins (abbreviated hnRNPs). 
The availability of genome sequences have allowed system-wide approaches to identify splicing 
enhancers and silencers that control splicing and led to significant insights into the “splicing code” [29]. 
These approaches have included machine learning approaches to utilize hundreds of features in  
pre-mRNAs including motifs bound by RNA binding proteins and RNA secondary structure 
predictions to predict in vivo splicing decisions [30]. Computer programmes have also been devised 
that can computationally predict positions of predicted splicing enhancers and silencers and the target 
sequences of RNA binding proteins in an input genomic sequence (e.g., Figure 3) [30–33]. The 
combination of these system-wide experimental and bioinformatic analyses show the splicing code is 
maintained as nucleotide information in the genome. The splicing code has similar importance to the 
genetic code that is deciphered to read amino acid sequences from mRNAs. However, the splicing 
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code is much more complex than the genetic code. While the genetic code uses triplet codons to 
specify amino acids, in the splicing code multiple sequence elements act in combination to decipher 
the exon/intron structure of pre-mRNAs [30]. 
Figure 3. Transcriptome-wide data can be used to predict the splicing code in specific 
genes. In this example sequences within a cassette exon in the mouse NASP gene have 
been analysed using genome and transcriptome wide datasets to pinpoint splicing control 
sequences. Firstly a Chasin Z-score plot was used that can identify sequences predictive of 
exonic splicing enhancers and silencers [32,34]: the four exonic splicing enhancer (ESE) 
sequences identified are shown as peaks in the plot above the sequence. In this example, 
these ESE sequences were individually mutated to test function in minigenes (the Chasin 
profiles of the mutants M1-M4 are shown compared to the wild type sequence: notice the 
change in the Z-score plot removes predicted ESE activity for each mutant). The positions 
of these ESEs mapped to binding sites for the splicing factor Tra2β, both individually 
identified using cross linking immunoprecipitation (CLIP) in the mouse testis and 
predicted from the in vivo binding site generated from transcriptome-wide Tra2β binding 
data from the mouse testis. This figure is adapted from [32].  
 
Because they are needed for exons to be spliced into mRNAs, ESE sequences have been maintained 
in exons as well as the codons that specify amino acid sequences [35]. The intronic sequences that 
flank exons are often also strongly conserved between species (Figure 4 shows as an example 
conserved nucleotide sequences flanking an exon in the mouse Neurexin3 gene downloaded from the 
UCSC genome browser). Comparison of the human and mouse genomes [1,36] which diverged 75 
million years ago show that alternative exons are usually flanked by much longer stretches of 
conserved intron sequences than constitutive exons, consistent with more elaborate control 
mechanisms [37,38]. Conservation in these exon flanking intron sequences in some cases is much 
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higher than in promoters, suggesting that one of the main functions of conserved noncoding sequences 
between mouse and human is the regulation of alternative splicing [37]. Even non-protein coding 
exons can be highly conserved in the genome. Noncoding exons include highly conserved “poison 
exons” (for example see Figure 5), that when included insert premature translational termination 
codons and lead to mRNA decay [32,39]. “Poison exons” are very important for auto-regulation of 
RNA binding proteins that control splicing [39,40]. Together these studies show the maintenance of 
splicing control sequences has had a significant impact in constraining genome evolution. 
Figure 4. A functional requirement to maintain splicing control sequences constrains 
evolution of the genome. This screenshot is downloaded from the UCSC genome browser [6] 
and shows conserved intron sequences flanking the alternatively spliced AS4 exon from 
the mouse Nrxn3 gene. The conserved sequences are shaded. At the top, the UCSC gene 
annotations show that this cassette exon is included in ¾ mRNA isoforms made from this 
gene. At the bottom the Phastcons plot shows that the flanking intron sequences are also 
highly conserved as well as the exon sequence (exons might be conserved because of their 
protein-coding content). Conservation of these intron sequences are likely important to 
control tissue-specific splicing of this exon by the spliceosome. Known alternative events 
are annotated on the UCSC track “Alt events”, and can be shown alongside the gene 
structure (here the cassette exon is annotated in the alt events track, and is in purple). 
 
Genome sequences have been used to help develop technologies aimed to globally dissect RNA 
processing pathways [41]. These technologies can identify the target sites of RNA binding proteins 
transcriptome-wide. In cross linking immunoprecipitation (abbreviated CLIP) experiments RNA 
binding proteins are cross-linked in situ to their target RNAs within intact cells using ultra violet 
irradiation, followed by immunoprecipitation of the RNA protein complexes and amplification by  
PCR [42–44]. Once unique target sites are identified by next generation sequencing (these are called 
CLIP tags), these can be mapped onto genome sequences to reveal the initial binding sites in the 
transcriptome. Transcriptome-wide CLIP analyses have enabled maps to be drawn of the target sites of 
RNA binding proteins relative to regulated exons, and these maps can be used to predict mechanisms 
of splicing control [45]. For example, CLIP tags of the RNA binding protein Tra2β that is needed for 
splicing inclusion for a regulated cassette exon in the NASP gene are shown in Figure 3 [32]. 
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Figure 5. Non protein coding exons are conserved in the genome. Some non-coding exons 
are highly conserved in the human genome and play important roles in controlling the 
expression levels of splicing regulator proteins. The TRA2A gene encodes the splicing 
regulator protein Tra2α and contains a poison exon that contains multiple stop codons and 
is only inserted into some mRNAs. Despite not containing coding information, the TRA2A 
poison exon is highly conserved across species (indicated by the Phastcons score). Notice 
that the TRA2A gene encodes also alternative 5' splice sites and uses alternative promoters. 
This screenshot was downloaded from the UCSC genome browser [6]. 
 
The completion of the human genome sequence enabled the development of comprehensive 
microarrays to interrogate gene expression. These global techniques include the development of  
splice-sensitive microarrays. These microarrays either detect specific exons in the transcriptome or the 
use of specific splice junctions and report splicing patterns in mRNA [46,47]. Transcriptome-wide 
patterns of alternative splicing can also be detected by RNAseq [48,49]. These technologies have been 
used to search for exons mis-spliced after depletion of particular RNA binding proteins from cells. By 
analysing thousands of exons in parallel the splicing events that are regulated by specific RNA binding 
proteins can be comprehensively identified. These experiments have shown some individual RNA 
binding proteins bind to and regulate similar mRNAs. For example, the NOVA protein regulates 
splicing of a functionally coherent set of genes involved in synapse function [50]. Other splicing 
regulators might similarly have coherent RNA functional targets, including T-STAR and SAM68 
which regulate regional alternative splicing of the synaptic neurexin genes in the brain [51,52]. 
Knowing which splicing events are regulated by what proteins at a global level has been used to 
derive general rules. For example, binding of the NOVA proteins upstream of exons tends to block 
splicing, while binding of the same proteins downstream of exons enhance splicing [44,45]. These 
rules governing the RNA motifs bound by NOVA and their role in activating or repressing associated 
exon inclusion are conserved between flies and mammals, although the actual target mRNAs are 
different [53]. Similar rules have also been uncovered for PTB and some other splicing regulator 
proteins [45,54,55]. Recent developments to understand the splicing code have compared binding 
maps for different RNA binding proteins, and show that some functionally collaborate with each other 
to generate tissue specific splicing patterns [56]. 
Transcriptome-wide insights have have also revealed the involvement of RNA binding proteins in 
other aspects of genome biology. Alu sequences are retro-transposable elements that frequently insert 
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into introns, and have sequence similarities to exons [57]. There are over 15,000 Alu sequences in the 
human genome, many of which are inserted into introns. The RNA binding protein hnRNP C has an 
important role for in protecting the transcriptome from potential mis-splicing caused by the insertion of 
Alu retrotransposable elements into genomic introns [58]. Depletion of hnRNPC leads to aberrant 
inclusion of around 1000 Alu-derived exons into the transcriptome. Alu sequences contain 
polypyrimidine tracts that potentially bind U2AF65, leading to them being aberrantly included into 
mRNAs, but this splicing is blocked by hnRNPC. 
3. Analysis of the Human Transcriptome Led to the Realisation That Most Human Genes Encode 
Alternatively Spliced mRNAs 
Historically genes have been defined in different ways by different people at different times. 
Following the human genome sequencing project, the fundamental definition of what a gene actually 
 is has been enriched, and to some extent clouded, by comparison of genome and transcriptome 
sequences [59,60]. Alternative mRNA isoforms can originate from the same genetic loci through use 
of alternative promoters and polyadenylation sites, and by the process of alternative splicing through 
which exons can be spliced into different combinations to give multiple mRNAs. Hence a “single 
gene” can encode multiple products. Alternative splicing fits into four different categories, depending 
on how variable splice junctions are utilised (Figure 6). In the simplest form of alternative splicing, 
called exon skipping, whole exons are either spliced into the mRNA or skipped (ignored by the 
spliceosome). Exon sequences can also be spliced into mRNA using different splice sites (alternative 
5' splice site or 3' splice sites can be selected). Whole introns can also be left in the mRNA (this is 
called intron retention). Transcriptome-wide analyses show that in humans exon skipping is the most 
frequent form of alternative splicing, and intron retention the least frequent [61]. 
Figure 6. Types of alternative splicing events detected in the human transcriptome. Exons 
are shown as boxes, introns as lines, and splicing patterns as broken lines. mRNAs can be 
made from individual genes can using multiple alternative events, including different types 
of splicing, to build up complex patterns of alternative spliced mRNAs. 
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Evidence provided by comparative genome and transcriptome sequences has shown alternative 
splicing to be extremely frequent. Before the human genome was published, random sequencing of 
human mRNAs from their 3' ends using oligo dT priming suggested ~40% of human genes encoded 
alternatively spliced mRNAs [62,63]. During the human genome sequencing project, reconstruction of 
mRNAs from the gene rich chromosomes 19 and 22 upped this estimate to 59% of genes encode 
alternative mRNAs, with 2–3 mRNA isoforms made/gene [1]. The use of microarrays to detect global 
patterns of alternative splicing indicated 73%–74% of human genes express alternatively spliced 
mRNA isoforms [46,64]. The most recently reported RNAseq analyses of the human transcriptome is 
consistent with ~95% of multi-exonic genes expressing variant mRNA isoforms, with a plateaux of 
10–11 isoforms/gene/cell line [65]. Usually one or two major mRNA isoforms predominate in a given 
cell line so many cell types will just express one major mRNA isoform [60,65,66]. 86% of genes have 
a minor isoform frequency of 15% or more, and more than 50% of alternative exons are tissue specific 
in expression [48,67]. Alternative events are now annotated on genome browsers like the UCSC 
genome browser (e.g., Figure 4) [6]. 
4. To What Extent Can Human Complexity Be Ascribed to Alternative Splicing? 
Proteins make up large components of human bodies. Prior to the genome sequence estimates of 
human gene numbers went as high as 100,000. An initial surprise from the human genome sequence 
was a much lower protein coding gene number, initially counted at around 23,000 [1,2]. The most 
recent gene counts from the ENCODE consortia suggest only 20,687 human protein coding genes [8]. 
The number of proteins expressed in a human cell is in contrast estimated to be ~100,000 [68,69]. This 
protein number represents an amplification factor of 5-fold compared to the counted number of genes. 
This total gene number in humans does not seem to be exceptionally higher than seemingly less 
sophisticated organisms. The genome of Haemophilus influenza contains 1743 predicted genes, the 
yeast Saccharomyces cerevisiae ~6000 genes, Drosophila melanogaster ~13,600 genes, and nematode 
worms 18,425 genes [70–72].  
This apparent failure of gene numbers to correlate with complexity has been called the gene number 
paradox, and counted as one of the major surprises from the human genome sequence. To what extent 
might alternative splicing and the resulting expansion in protein coding information help explain 
developmental and physiological complexity in humans (Figure 7)? Until recently this question has 
been difficult to address, since the higher number of mRNA and EST sequences available from 
humans made comparisons of alternative splicing frequency with other species biased. However, a 
recent modencode project based on RNAseq analysis to look at alternative splicing in C. elegans found 
~25% alternative splicing in 5000 genes, with around 30% of these being alternatively spliced between 
different developmental stages [73]. In depth experiments using RNAseq and tiling arrays do show a 
lower frequency (60.7%) of genes in the fruitfly are alternatively spliced than in humans, often in a 
developmental or sex-specific fashion [74]. 
Genes 2014, 5 244 
 
 
Figure 7. Alternative splicing amplifies genome information. Alternative splicing amplifies 
information in the human transcriptome relative to the genome. 
 
Hence amongst multicellular animals investigated in detail, humans do seem to exhibit higher levels 
of alternative splicing, which might lend credence to the idea that alternative splicing may be a factor 
contributing to human sophistication. If phylogenetic differences in alternative splicing frequency 
correlate with complexity, one might expect a decreased level in single celled organisms compared 
with multicellular organisms. On the one level less introns are found in the single celled baker’s yeast 
Saccharomyces cerevisiae: only 5% of genes contain introns in this yeast (290/6000 genes). However, 
these lower intron numbers are a bit misleading. The reason for a low overall intron number in this 
yeast is that many introns have been lost because of reverse transcriptase activity converting mRNAs 
into cDNAs, which then re-integrate into the genome through high levels of homologous recombination 
replacing originally intron containing genes [75]. While intron-containing genes generally are rare in 
yeast, alternative splicing of some of these introns are specifically utilised to control developmental 
timing of during meiosis that takes place under conditions of limiting nutrients [76,77] so alternative 
splicing is used to control a complex stage in the lifecycle of this single celled organism. Taken as a 
whole, it is difficult to draw general correlations between overall frequencies of alternative splicing 
and organism sophistication. 
Alternative splicing patterns can also evolve rapidly and sometimes differ between closely related 
species. For example, despite almost 99% identity in protein coding information, comparative 
transcriptome analyses have shown that 6%–8% of alternative spliced exons have different inclusion 
patterns between humans and chimps. These observations are consistent with alternative splicing 
contributing to species-species differences, and transcriptomes being more distinct between species 
than protein coding information [78]. Although the major conclusion from evolutionary comparisons is 
that much alternative splicing is not conserved between species, comparative genomics show some 
alternative exons have been highly conserved during evolution [79–81]. These include the highly 
conserved “AS4” alternative exon in the Neurexin3 gene (abbreviated Nrxn3, Figure 4) that is 
conserved across the vertebrate lineage [51]. The Neurexin genes have been linked with autism and 
schizophrenia, and mice genetically engineered to be unable to regulate this AS4 alternative exon in 
the Nrxn3 gene have different synaptic activity in the brain [82]. 
Post-genome analyses have also addressed the question what alternative splicing does. Protein 
sequences encoded by alternatively spliced exons are frequently involved in protein-protein interaction 
networks and contain signalling domains [83,84]. Some alternatively spliced mRNAs encode proteins 
with clearly different functional activity. For example, different mRNA splice isoforms encoding the 
FOXP1 transcription factor are made between neural stem cells and differentiated cells, and these 
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encode proteins that activate different promoters [85]. Alternative splicing regulators have been 
implicated in human cognitive diseases like autism [86]. Different groups of genes are regulated by 
alternative splicing from those regulated by transcription [87]. 
Alternative splicing pathways have been shown to have important roles in controlling development, 
and some human diseases are caused by defects in alternative splicing including the multi-system 
disorder myotonic dystrophy [87]. However, individual RNA binding proteins likely regulate 
coordinated splicing programmes of many target exons, and each of these individual exons might only 
have somewhat subtle biological contributions. Furthermore, post-genome technologies are also 
starting to introduce a note of caution in the interpretation of high levels of alternative splicing. Some 
lower abundance splice variants might be non-functional isoforms that occur as a result of low 
frequency events mistakes in the splicing process if they are neither evolutionarily conserved nor 
protein-coding [21,88]. Hence the frequency of functional alternative splicing is likely to be lower than 
the total frequency of all alternative splicing events. 
5. Human Genome Packaging into Chromatin Correlates with Its Intron/Exon Structure 
Post genome analyses have shown that the genome and transcriptome are intimately linked. In 
particular the exon/intron structure of genes correlates with how the genome is packaged. Within the 
nucleus the genome is wrapped around protein complexes called nucleosomes to form chromatin. Each 
nucleosome is itself made up of eight positively charged histone molecules that can be modified by the 
addition of small chemical groups (typically methyl and acetyl groups) [89]. Packaging of the genome 
within chromatin is important to enable storage of chromosomes within the comparatively small space 
afforded by the nuclear volume.  
After experimental treatment of chromatin with the enzyme DNAse I, the DNA sequences wrapped 
around nucleosomes remain protected, while the DNA linkages joining nucleosomes together become 
degraded. Genome-wide analysis of sequences protected from DNAse I digestion in humans and other 
species indicate a 1.5 fold enrichment of exon sequences over nucleosomes compared to intron 
sequences [90,91]. This means that in chromatin exons are preferentially (but not exclusively) 
associated with nucleosomes. This is likely to have a biochemical explanation: exon sequences are 
GC-enriched, while their flanking intron sequences are AT-rich. Nucleosomes interact more strongly 
with GC-rich sequences, which likely help anchor exons to nucleosomes. The association of exons 
with nucleosomes has in turn had important implications for genome evolution. A length of  
~150 nucleotides of DNA is needed to wrap around a nucleosome, and this is also the average size of 
an exon. Hence nucleosome wrapping has placed an evolutionary constraint on exon size, while in 
contrast introns have been able to expand in size to thousands of nucleotides. 
6. Most Splicing Occurs Co-Transcriptionally 
Another important connection between the genome and the transcriptome is their physical proximity 
during important RNA processing steps. In several species including humans much pre-mRNA 
splicing has been shown to take place co-transcriptionally [92]. This means that “full length”  
pre-mRNA copies of genes are not made. Instead processing takes place as pre-mRNAs are produced 
on nascent pre-mRNAs still attached to RNA polymerases engaged in transcription. Deep sequencing 
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of fractionated nascent RNA in human cell lines and total RNA in the brain show that exons located 
more upstream in genes are most likely to be spliced on nascent RNA [65,93,94]. Transcription of the 
genome also functionally depends on components more “traditionally” thought to be involved in 
splicing. Transcriptome-wide analysis of gene expression following depletion of U1 snRNP (a 
component of the spliceosome that recognises 5' splice sites) has shown that high nuclear concentrations 
of U1 snRNP are needed to prevent premature intragenic polyadenylation at sites upstream of the 
proper 3' boundary of genes [95]. 
The fact that splicing takes place on chromatin during ongoing transcription has important 
implications for alternative splicing patterns. Single molecule experiments have shown that 
nucleosomes slow down the progress of transcription [96,97]. This means that the time taken to 
traverse nucleosomes can provide pauses in RNA polymerase II elongation, allowing the spliceosome 
a window to assemble on nascent pre-mRNA. Nucleosomes have thus been described as “speed 
bumps” [98–101]. Interestingly only true exons, and not pseudoexons, are associated with 
nucleosomes [90,91]. Exon association with nucleosomes is likely to help in their recognition by the 
spliceosome. Pauses in transcriptional elongation on bona fide exons might facilitate spliceosome 
assembly before potentially competing splice sites in downstream pseudoexons can be transcribed. 
Changes in chromatin structure can locally speed up or slow down transcription within genes and be 
important for controlling alternative splicing [99]. Local transcriptional pauses would provide 
spliceosomes a longer “window” of time in which to assemble and sometimes even carry out splicing 
of an exon before a competing downstream splice site appears [102,103]. Faster elongating RNA 
polymerase II enzymes would give spliceosomes less time to assemble on nascent pre-mRNA before 
competing exons were transcribed, and so would favour exon skipping. In some cases changes in 
histone modification can recruit or stabilise RNA binding proteins which regulate splicing of the  
pre-mRNAs made from the gene [104]. The interactions between the different processes in gene 
expression have been recently reviewed in [105]. 
7. Conclusions 
The human genome sequence has provided a catalyst for understanding the transcriptome.  
System-wide approaches of the transcriptome have led to a fuller appreciation of how genomes work 
including how the human genome operates with a finite gene number and providing a system wide 
view of RNA processing. 
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